Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions

Diagnostic ImagingNeoplasms

Interventions

DRUG

BAY94-9392

Trial Locations (3)

München

Stanford

Seoul